Raia Drogasil (BSP:RADL3) EV-to-Revenue : 1.49 (As of May. 03, 2024)

View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Raia Drogasil's enterprise value is R$50,631 Mil. Raia Drogasil's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was R$33,974 Mil. Therefore, Raia Drogasil's EV-to-Revenue for today is 1.49.

The historical rank and industry rank for Raia Drogasil's EV-to-Revenue or its related term are showing as below:

BSP:RADL3' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.75 Med: 1.58 Max: 7.04
Current: 1.49

During the past 13 years, the highest EV-to-Revenue of Raia Drogasil was 7.04. The lowest was 0.75. And the median was 1.58.

BSP:RADL3's EV-to-Revenue is ranked better than
57.4% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.84 vs BSP:RADL3: 1.49

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-03), Raia Drogasil's stock price is R$25.64. Raia Drogasil's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was R$19.91. Therefore, Raia Drogasil's PS Ratio for today is 1.29.

Raia Drogasil EV-to-Revenue Historical Data

The historical data trend for Raia Drogasil's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil EV-to-Revenue Chart

Raia Drogasil Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.33

2.27

1.86

1.54

1.68

Raia Drogasil Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															1.54	1.51	1.79	1.64	1.68

Competitive Comparison of Raia Drogasil's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, Raia Drogasil's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raia Drogasil's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's EV-to-Revenue falls into.

Raia Drogasil EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Raia Drogasil's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	50630.919	/	33973.79
	=	1.49

Raia Drogasil's current Enterprise Value is R$50,631 Mil.
Raia Drogasil's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$33,974 Mil.

Raia Drogasil (BSP:RADL3) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Raia Drogasil's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	25.64	/	19.914
	=	1.29

Raia Drogasil's share price for today is R$25.64.
Raia Drogasil's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$19.91.

Raia Drogasil EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil (BSP:RADL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

RADLY:USA

Address

Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000

Website

https://ri.rd.com.br

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines